Insights From the Editor

The push to ban ED drugs from Medicare reimbursement isn't about their "lifestyle" classification.

Patrick Clinton
Editor-in-Chief

Pharma has more in common with tobacco than it may think.

Sarah Wealleans
Landor Associates

Resources People Update

Calendar of Events

Advertisers Index